Biotinylated antibody against human histone H3 that is dimethylated on Lysine 79. This antibody is intended for use in AlphaLISA™ no-wash epigenetic assays using DOT1L methyltransferase with oligonucleosome substrates.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Biochemical Enzymatic Assay |
Biotinylated antibody against human histone H3 that is dimethylated on Lysine 79. This antibody is intended for use in AlphaLISA™ no-wash epigenetic assays using DOT1L methyltransferase with oligonucleosome substrates.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
AlphaLISA™ antibody designed to detect Human Histone H3 that is dimethylated on Lysine 79 in a homogeneous AlphaLISA assay. Broad species cross-reactivity is expected based on sequence similarity. Source of antibody: monoclonal. The biotin-anti-dimethyl-Histone H3 Lysine 79 (H3K79me2) AlphaLISA antibody was used for the development and optimization of a DOT1L methyltransferase assay using oligonucleosomes as substrate. A technical note describing the assay is available in our product literature.
Application |
Biochemical Enzymatic Assay
|
---|---|
Automation Compatible |
Yes
|
Brand |
AlphaLISA
|
Detection Modality |
Alpha
|
Host Species |
Human
|
Molecular Modification |
Methylation
|
Product Group |
Antibody
|
Shipping Conditions |
Shipped in Blue Ice
|
Target Class |
Epigenetics
|
Technology |
Alpha
|
Unit Size |
2 µg
|
Are you looking for resources, click on the resource type to explore further.
Epigenetic modifications in cancer
The field of epigenetics has revealed revolutionary methods for understanding heredity...
We are here to answer your questions.